Association Between Lipid Accumulation Product and Target Organ Damage in Elderly Population: The Northern Shanghai Study

References

• Fox CS, Massaro M, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/circulationaha.106.67535517576866
   PubMed Web of Science ®Google Scholar
• Preis SR, Massaro M, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring, Md). 2010;18(11):2191–2198. doi:10.1038/oby.2010.59
   PubMed Web of Science ®Google Scholar
• Camhi SM, Bray GA, Bouchard C, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring, Md). 2011;19(2):402–408. doi:10.1038/oby.2010.248
   PubMed Web of Science ®Google Scholar
• Shah RV, Murthy VL, Abbasi A, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC. 2014;7(12):1221–1235. doi:10.1016/j.jcmg.2014.07.017
   Google Scholar
• Neeland IJ, Turer T, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308(11):1150–1159. doi:10.1001/2012.jama.1113222990274
   PubMed Web of Science ®Google Scholar
• Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26. doi:10.1186/1471-2261-5-2616150143
   PubMedGoogle Scholar
• Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726–1731. doi:10.1093/humrep/dep07219329517
   PubMed Web of Science ®Google Scholar
• Oh J-Y, Sung Y-A, Lee HJ. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabetic Med. 2013;30(4):436–442. doi:10.1111/dme.1205223075457
   PubMed Web of Science ®Google Scholar
• Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151–153. doi:10.2337/diacare.29.1.15116373916
   PubMed Web of Science ®Google Scholar
• Tellechea ML, Aranguren FA, Martinez-Larrad M, Serrano-Rios M, Taverna MJ, Frechtel GD. Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care. 2009;32(7):e85. doi:10.2337/dc08-228419564464
   PubMedGoogle Scholar
• Taverna MJT, Martínez-Larrad MT, Frechtel GD, Serrano-Ríos M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011;164(4):559–567. doi:10.1530/eje-10-103921262912
   PubMed Web of Science ®Google Scholar
• Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian Population. Metab Syndr Relat Disord. 2018;16(5):240–245. doi:10.1089/met.2017.011929648916
   PubMed Web of Science ®Google Scholar
• Brahimaj A, Rivadeneira F, Muka T, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62(9):1581–1590. doi:10.1007/s00125-019-4921-2.31183505
   PubMed Web of Science ®Google Scholar
• Wehr E, Gruber H-J, Giuliani A, Möller R, Pieber TR, Obermayer-Pietsch B. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab. 2011;96(6):E986–90. doi:10.1210/jc.2011-003121470992
   PubMed Web of Science ®Google Scholar
• Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring, Md). 2010;18(9):1836–1844. doi:10.1038/oby.2009.453
   PubMed Web of Science ®Google Scholar
• Schunkert H. Obesity and target organ damage: the heart. Int J Obes Rel Metab Disord. 2002;S15–20. doi:10.1038/sj.ijo.0802214
   Web of Science ®Google Scholar
• De Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. Obesity and target organ damage: the kidney. Int J Obes Rel Metab Disord. 2002;S21–4. doi:10.1038/sj.ijo.0802213
   Web of Science ®Google Scholar
• Palatini P, Saladini F, Mos L, et al. Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients. Int J Obes. 2013;37(2):224–229. doi:10.1038/ijo.2012.32.
   PubMed Web of Science ®Google Scholar
• Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18(11):1705–1710. doi:10.1093/europace/euw00727402623
   PubMed Web of Science ®Google Scholar
• Ji H, Xiong J, Yu S, et al. Northern Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design. BMJ Open. 2017;7(3):e013880. doi:10.1136/bmjopen-2016-013880.
   Web of Science ®Google Scholar
• Beck GJ, Berg RL, Coggins C, et al. Design and statistical issues of the modification of diet in renal disease trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials. 1991;12(5):566–586. doi:10.1016/0197-2456(91)90069-x1664792
   PubMedGoogle Scholar
• Roriz AKC, Passos LCS, de Oliveira CC, et al. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9(7):e103499. doi:10.1371/journal.pone.010349925078454
   PubMed Web of Science ®Google Scholar
• Ganguly S, Ray L, Kuruvila S, Nanda SK, Ravichandran K. Lipid accumulation product index as visceral obesity indicator in psoriasis: a case-control study. Indian J Dermatol. 2018;63(2):136–140. doi:10.4103/ijd.IJD_315_16.29692455
   PubMed Web of Science ®Google Scholar
• Rotter I, Rył A, Szylińska A, Pawlukowska W, Lubkowska A, Laszczyńska M. Lipid Accumulation Product (LAP) as an index of metabolic and hormonal disorders in aging men. Exp Clin Endocrinol Diabetes. 2017;125(3):176–182. doi:10.1055/s-0042-116071.27898988
   PubMed Web of Science ®Google Scholar
• Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis. 2010;9(1):45. doi:10.1186/1476-511x-9-4520459710
   PubMed Web of Science ®Google Scholar
• Tian T, Pei H, Chen Z, et al. Comparison of lipid accumulation product and body mass index as indicators of diabetes diagnosis among 215,651 Chinese adults. Peer J. 2020;8:e8483. doi:10.7717/peerj.848332095339
   PubMed Web of Science ®Google Scholar
• Wang Z, He S, Chen X. Capacity of different anthropometric measures to predict diabetes in a Chinese population in southwest China: a 15-year prospective study. Diabetic Med. 2019;36(10):1261–1267. doi:10.1111/dme.1405531215075
   PubMed Web of Science ®Google Scholar
• Biyik Z, Guney IJ. Lipid accumulation product and visceral adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease. Eur Rev Med Pharmacol Sci. 2019;23(5):2167–2173. doi:10.26355/eurrev_201903_17262.30915762
   PubMed Web of Science ®Google Scholar
• Wang H, Li Z, Guo X, et al. The impact of nontraditional lipid profiles on left ventricular geometric abnormalities in general Chinese population. BMC Cardiovasc Disord. 2018;18(1):88. doi:10.1186/s12872-018-0829-x29739326
   PubMed Web of Science ®Google Scholar
• Wang H, Sun Y, Li Z, et al. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. BMC Cardiovasc Disord. 2018;18(1):62. doi:10.1186/s12872-018-0798-0.29631555
   PubMed Web of Science ®Google Scholar
• Wung C, Lee M, Wu P, Huang J, Chen S. Obesity-related indices are associated with peripheral artery occlusive disease in patients with Type 2 diabetes mellitus. J Pers Med. 2021;11(6):533. doi:10.3390/jpm1106053334207835
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605. doi:10.1093/eurheartj/ehl25417000623
   PubMed Web of Science ®Google Scholar
• Lopes-Vicente WR, Rodrigues S, Cepeda FX, et al. Arterial stiffness and its association with clustering of metabolic syndrome risk factors. Diabetol Metab Syndr. 2017;9:87. doi:10.1186/s13098-017-0286-129090024
   PubMed Web of Science ®Google Scholar
• Topouchian J, Labat C, Gautier S, et al. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens. 2018;36(4):824–833. doi:10.1097/hjh.000000000000163129324585
   PubMed Web of Science ®Google Scholar
• Zachariah J, Rong J, Larson M, et al. Metabolic predictors of change in vascular function: prospective associations from a community-based cohort. Hypertension (Dallas, Tex:1979). 2018;71(2):237–242. doi:10.1161/hypertensionaha.117.10054
   PubMed Web of Science ®Google Scholar
• Meani P, Maloberti A, Sormani P, et al. Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up. Blood Press. 2018;27(1):32–40. doi:10.1080/08037051.2017.137806928922954
   PubMed Web of Science ®Google Scholar
• Maloberti A, Rebora P, Andreano A, et al. Pulse wave velocity progression over a medium-term follow-up in hypertensives: focus on uric acid. J Clin Hypertens. 2019;21(7):975–983. doi:10.1111/jch.13603
   Web of Science ®Google Scholar
• Maloberti A, Bruno R, Facchetti R, et al. THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS. Eur J Intern Med. 2020;76:107–109. doi:10.1016/j.ejim.2020.02.00532081529
   PubMed Web of Science ®Google Scholar
• Dai D, Chang Y, Chen Y, et al. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the Rural Population in Northeast China. Int J Environ Res Public Health. 2016;13:12. doi:10.3390/ijerph13121231
   Web of Science ®Google Scholar
• Zhang K, Li Q, Chen Y, Wang N, Lu Y. Visceral adiposity and renal function: an observational study from SPECT-China. Lipids Health Dis. 2017;16(1):205. doi:10.1186/s12944-017-0597-029078775
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Wang J, et al. Lipid accumulation product is associated with urinary albumin-creatinine ratio in Chinese prediabetic population: a report from the REACTION Study. Diabetes Metab Syndr Obes. 2021;14:2415–2425. doi:10.2147/dmso.S31075134093028
   PubMed Web of Science ®Google Scholar
• Jx N, Mb C, de Sousa RML, et al. Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 2015;14:62. doi:10.1186/s12944-015-0061-y26104466
   PubMed Web of Science ®Google Scholar
• Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women. Obesity (Silver Spring, Md). 2011;19(9):1873–1880. doi:10.1038/oby.2011.42
   Web of Science ®Google Scholar
• Hosseinpanah F, Barzin M, Mirbolouk M, et al. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study. Eur J Prev Cardiol. 2016;23(2):187–193. doi:10.1177/2047487314558771.25381336
   PubMed Web of Science ®Google Scholar
• Maloberti A, Bombelli M, Vallerio P, et al. Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects. Nutri Metabol Cardiovasc Dis. 2021;31(4):1044–1052. doi:10.1016/j.numecd.2020.11.011
   Web of Science ®Google Scholar